Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: Variations with increasing levels of HbA1c

Diabetes Care

Volumn 26, Issue 3, 2003, Pages 881-885

  Monnier, Louis ^a   Lapinski, Hélène ^a   Colette, Claude ^b  

^a LAPEYRONIE HOSPITAL   (France)

^b UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD GLUCOSE MONITORING; CALCULATION; CIRCADIAN RHYTHM; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE;

BLOOD GLUCOSE; CIRCADIAN RHYTHM; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD;

EID: 0042166232     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.3.881     Document Type: Article

References (18)

1. American Diabetes Association: Postprandial blood glucose (Consensus Statement). Diabetes Care 24:775-778, 2001
2. Avignon A, Radauceanu A, Monnier L: Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care 20:1822-1826, 1997
3. 1c interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control. Diabetes Care 24:2023-2029, 2001
4. Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD: Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 37:1020-1024, 1988
5. Riddle MC: Evening insulin strategy (Review). Diabetes Care 13:676-686, 1990
6. Monnier L, Colette C, Rabasa-Lhoret R, Lapinski H, Caubel C, Avignon A, Boniface H: Morning hyperglycemic excursions: a constant failure in the metabolic control of non-insulin-using patients with type 2 diabetes. Diabetes Care 25: 737-741, 2002
7. Dinneen S, Gerich JE, Rizza R: Carbohydrate metabolism in non-insulin-dependent diabetes mellitus. N Engl J Med 327: 707-713, 1992
8. Monnier L: Is postprandial glucose a neglected cardiovascular risk factor in type 2 diabetes? Europ J Clin Invest 30 (Suppl. 2): 3-11, 2000
9. The Expert Committee in the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 25 (Suppl. 1):S5-S20, 2002
10. American Diabetes Association: Standards of medical care for patients with diabetes mellitus (Position Statement). Diabetes Care 25 (Suppl. 1):S33-S49, 2002
11. Miller RG: Simultaneous Statistical Interference, 2nd ed. New York, Springer-Verlag, 1981
12. Monsod TP, Flanagan DE, Rife F, Saenz R, Caprio S, Sherwin RS, Tamborlane WV: Do sensor glucose levels accurately predict plasma glucose concentrations during hyperglycemia and hyperinsulinemia? Diabetes Care 25:889-893, 2002
13. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M: Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care 25:750-786, 2002
14. The DECODE Study group on behalf of the European Diabetes Epidemiology Group: Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 354:617-621, 1999
15. Bonora E, Muggeo M: Postprandial blood glucose as a risk factor for cardiovascular disease in type II diabetes: the epidemiological evidence. Diabetologia 44:2107-2114, 2001
16. UK Prospective Diabetes Study (UKPDS) group: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
17. Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H, Ziegelasch HJ, Lindner J: Risk factors for myocardial and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 39:1577-1583, 1996
18. 1c in the Diabetes Control and Complications Trial. Diabetes Care 25:275-278, 2002